Synopsis
Synopsis
0
VMF
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Mls001401438
2. Chembl1895091
3. Hms2051p14
4. Hms2233m10
5. Ccg-101038
6. Nc00288
7. Smr000471620
Molecular Weight | 478.5 g/mol |
---|---|
Molecular Formula | C23H30N2O9 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 10 |
Exact Mass | 478.19513054 g/mol |
Monoisotopic Mass | 478.19513054 g/mol |
Topological Polar Surface Area | 166 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 507 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Alpha-bromo-4-benzoloxy-3- nitroacetophenone
CAS Number : 43229-01-2
End Use API : Formoterol Fumarate
About The Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domesti...
(4-Methoxy phenyl)-iso propyl benzyl amine hydroch...
CAS Number : 1049695-95-5
End Use API : Formoterol Fumarate
About The Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domesti...
CAS Number : 43229-70-5
End Use API : Formoterol Fumarate
About The Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domesti...
N-(2-hydroxy-5-((RS)-1-hydroxy-2-(((RS)-1-(4-metho...
CAS Number : 73573-87-2
End Use API : Formoterol Fumarate
About The Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services co...
CAS Number : 101-98-4
End Use API : Formoterol Fumarate
About The Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our cor...
4-Benzyloxy-3-Nitro-Alpha-[N-benzyl-N-[1-methyl-2-...
CAS Number :
End Use API : Formoterol Fumarate
About The Company : Gangwal is a progressive and innovative business group with a clear vision and ascertaining new challenges, having a strong foundation supported by strong pilla...
N-O-Dibenzyl Formoterol
CAS Number :
End Use API : Formoterol Fumarate
About The Company : Gangwal is a progressive and innovative business group with a clear vision and ascertaining new challenges, having a strong foundation supported by strong pilla...
2-Bromo-4'-Benzyloxy-3'-nitroacetophenone
CAS Number : 43229-01-2
End Use API : Formoterol Fumarate
About The Company : Hiray Pharma Solutions is an international end-to-end CDMO, facilitating the development and manufacturing of important drug products and key intermediates arou...
2-Bromo-4’-Benzyloxy-3’-Nitro Acetophenone
CAS Number : 43229-01-2
End Use API : Formoterol Fumarate
About The Company : SLN Pharmachem was setup in 1997 with an objective to provide technology based products (Intermediates) for Pharmaceutical, Cosmetic and Fine Chemical Industry....
CAS Number : 43229-70-5
End Use API : Formoterol Fumarate
About The Company : SLN Pharmachem was setup in 1997 with an objective to provide technology based products (Intermediates) for Pharmaceutical, Cosmetic and Fine Chemical Industry....
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
Patent Expiration Date : 2031-03-17
BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US Patent Number : 8815258
Drug Substance Claim :
Drug Product Claim :
Application Number : 212122
Patent Use Code : U-2889
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-17
Patent Expiration Date : 2029-04-07
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
US Patent Number : 8616196
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21929
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-07
Patent Expiration Date : 2038-10-05
BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US Patent Number : 11331442
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212122
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-10-05
Patent Expiration Date : 2026-04-10
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
US Patent Number : 7587988
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21929
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-04-10
Patent Expiration Date : 2029-04-16
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
US Patent Number : 8528545*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 21929
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-16
Patent Expiration Date : 2031-03-17
FORMOTEROL FUMARATE; GLYCOPYRROLATE
US Patent Number : 8815258
Drug Substance Claim :
Drug Product Claim :
Application Number : 208294
Patent Use Code : U-2889
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-17
Patent Expiration Date : 2027-03-26
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
US Patent Number : 8387615
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21929
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-03-26
Patent Expiration Date : 2029-04-16
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
US Patent Number : 8528545*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 21929
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-16
Patent Expiration Date : 2030-05-28
FORMOTEROL FUMARATE; GLYCOPYRROLATE
US Patent Number : 9463161
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208294
Patent Use Code : U-2889
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-05-28
Patent Expiration Date : 2029-03-13
ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE
US Patent Number : 10085974
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210595
Patent Use Code : U-2513
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-13
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?